FELIPE
COUÑAGO LORENZO
Investigador en el periodo 2012-2022
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (6)
2024
-
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66
2023
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
2022
-
Bone health and therapeutic agents in advanced prostate cancer
Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1
2021
-
A data mining based clinical decision support system for survival in lung cancer
Reports of Practical Oncology and Radiotherapy, Vol. 26, Núm. 6, pp. 839-848
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
Management of resectable stage iii-n2 non-small-cell lung cancer (Nsclc) in the age of immunotherapy
Cancers, Vol. 13, Núm. 19